Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1658 of 6351
-
Malaria-Fighting drug given to entire villages shows promise
Disease control CompletedTheoretically, so long as there is a sink-source for malaria, transmission could be sustained at very low level (even at sub-microscopic oscillation) and reintroduce malaria either as sporadic cases or as resurgent outbreak. Uncertainty or shortage in financing has typically limi…
Phase 4 • Sponsor: Shoklo Malaria Research Unit • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Tango therapy may ease chemo nerve pain in breast cancer survivors
Symptom relief Recruiting nowUp to 80% of breast cancer survivors experience chemotherapy-induced neuropathy that impairs quality of life and increases fall risk long into survivorship, yet treatment options for neuropathy remain limited. The successful treatment will target neurophysiologic mechanisms for r…
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
One-Week radiation shows promise for breast cancer patients
Disease control Recruiting nowThis study evaluates the rates of radiation-specific toxicity, quality of life, and oncologic outcomes for early-stage breast cancer and ductal carcinoma in situ treated with 5-fraction whole breast irradiation (WBI) with a simultaneous integrated tumor bed boost (SIB). SIB refer…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Immune cell shot aims to tame tough lupus cases
Disease control Recruiting nowThis is an investigator-initiated, open-label, single-arm study to determine safety and preliminary efficacy of NK010 or NK042 in combination with rituximab (RTX) for the treatment of patients with refractory systemic lupus erythematosus (SLE) or lupus nephritis (LN) in China.
Phase 1 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill aims to slash hidden heart risk factor
Disease control CompletedThe main purpose of this study is to evaluate the efficacy and safety of HRS-5346 in adult participants with elevated Lp(a) at high risk for cardiovascular events.
Phase 2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Phone buddies fight HIV: new study tests peer navigator app for young women in zambia
Prevention OngoingThe goal of this clinical trial is to learn if the TwySHE intervention can increase the use of HIV prevention in at-risk female university students aged 18-24 in Zambia. The main question it aims to answer is: • Can a mhealth peer navigator intervention effectively promote HIV p…
Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Peer support after hospital stay may cut overdose and infection risk
Disease control Recruiting nowThe purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting, called the THRIVE intervention. The main question it aims to answer is: Will participants receiving …
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can remote exercise and weight loss boost heart failure Patients' stamina?
Symptom relief Recruiting nowHeart failure with preserved ejection fraction (HFpEF) is associated with a high morbidity and mortality burden. There are limited pharmacological options available for the treatment of HFpEF. Exercise intolerance (EI) is the cardinal symptom of HFpEF, which manifests as dyspnea …
Phase 2/3 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Dissolving stent could revolutionize treatment for long heart blockages
Disease control Recruiting nowThe study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm length.
Sponsor: Biotronik AG • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New pill aims to stall advanced prostate cancer when hormone drugs fail
Disease control Recruiting nowThe purpose of this clinical trial is to determine if GZ17-6.02 delays progression of castration-resistant prostate cancer.
Phase 1 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis is an open label, multi-center, multiple dose Phase IB/II study to evaluate the safety, tolerability and efficacy of SHR-1826 for injection in subjects with advanced solid tumors.
Phase 1/2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Weekly insulin shot could replace daily injections for type 2 diabetes
Disease control OngoingThis study will be conducted to compare the efficacy, safety and patient-reported outcome of once-weekly GZR4 and once-daily Insulin Glargine U100 in Combination with Insulin Aspart (with or without Non-Insulin Antidiabetic Agents) in Subjects with Type 2 Diabetes Mellitus (T2DM)…
Phase 3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could skipping bowel prep make surgery easier on patients?
Knowledge-focused CancelledThis is a prospective randomized study of patients who are scheduled to undergo minimally invasive robotic gynecologic surgery. Patients will be randomized to require either pre-surgical bowel preparation vs. no bowel preparation. The effect of bowel preparation on intraoperative…
Sponsor: Henry Ford Health System • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New study aims to ease depression and anxiety in expecting and new mothers
Symptom relief Recruiting nowPerinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interv…
Sponsor: Kenyatta National Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a Stop-Smoking pill tame dangerous heart rhythms?
Disease control CompletedThis is an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial designed to evaluate the preliminary efficacy of varenicline tartrate in patients with frequent PVCs complicated by myocardial infarction (MI). The protocol…
Phase 2 • Sponsor: Yihan Chen • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New stomach bug treatment battle: which drug combo wins?
Disease control Recruiting nowThis study is a randomized, open-label, parallel-group clinical trial designed to compare two 14-day dual therapies for the eradication of Helicobacter pylori (H. pylori) infection. Participants will be randomly assigned to receive either tegoprazan 50 mg twice daily plus amoxici…
Phase 2/3 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New injection could ease back pain without surgery
Disease control Recruiting nowVIA Disc NP is a non-surgical intervention intended to supplement nucleus pulposus tissue in degenerated intervertebral discs. This is a randomized, sham-controlled, multi-center, double-blind clinical trial with an open label roll-in period of one participant per site in which …
Sponsor: VIVEX Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heat-Sensing camera could speed up infection diagnosis in kids
Diagnosis Recruiting nowThis is a pilot proof of feasibility study to explore the efficacy of High Resolution Infrared Thermographic Imaging (HRTI) to assist with the detection of musculoskeletal infections in children. In HRTI, a sensitive thermal camera is used to capture the temperature profile of th…
Sponsor: Sheffield Children's NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Magnetic helmet trial aims to slow deadly brain tumors
Disease control Recruiting nowThe clinical investigation is a non-randomized, multicenter, open-label, prospective, exposure-time escalation clinical investigation. The clinical investigation is designed to assess the clinical safety and performance of the Oncomagnetic Device.
Sponsor: BioTex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to test the safety and efficacy of BMS-986482 alone and as combination therapy in participants with advanced solid tumors.
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC